-
Product Insights
MSD – Ohio River Tunnel Extension – Kentucky
Equip yourself with the essential tools needed to make informed and profitable decisions with our MSD - Ohio River Tunnel Extension - Kentucky report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
MSD – Ballydine Pharmaceutical Plant Upgrade – Munster
Equip yourself with the essential tools needed to make informed and profitable decisions with our MSD - Ballydine Pharmaceutical Plant Upgrade - Munster report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
MSD Capital/ Retail Connection/ Trammell Crow – Knox Street Mixed-Use Development – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our MSD Capital/ Retail Connection/ Trammell Crow - Knox Street Mixed-Use Development - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
MSD Solar PV Park
The MSD Solar PV Park is a 7.3MW solar PV power project located in Tipperary, Ireland. It was developed by ESB Power Generation. The project is currently active. The project started its commercial operations in 2022. The project is owned by ESB Power Generation. MSD Solar PV Park profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year, capital...
-
Product Insights
MSD Capital/ RXR Realty/ TF Cornerstone – Project Commodore Mixed-Use Development – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our MSD Capital/ RXR Realty/ TF Cornerstone - Project Commodore Mixed-Use Development - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Company Profile
![]()
Merck & Co Inc – Company Profile
Merck & Co Inc (Merck) is a biopharmaceutical company focused on the discovery, development, manufacturing and marketing of prescription medicines, biologic therapies, vaccines, and animal health products. It offers prescription products for therapy areas related to cardiovascular, cancer, immune disorders, infectious, respiratory, and diabetes. The company provides animal health products such as vaccines, poultry products, livestock products and aquaculture products. Merck sells medicines to drug wholesalers, retailers, hospitals, government agencies and managed health care providers, and animal health products to...
Add to Basket -
Company Profile
![]()
BioInvent International AB – Company Profile
BioInvent International AB (BioInvent) focuses on the research and development of antibodies for the treatment of cancer. The company uses n-CoDeR, an inhouse platform for developing immuno-oncology drugs. n-CoDeR is an antibody library used for the rapid selection, screening and identification of antibodies. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin’s lymphoma and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers. It has collaborations and partners with several leading pharmaceutical companies including Pfizer, MSD...
Add to Basket -
Thematic Analysis
![]()
Environmental Trends in Healthcare – Thematic Intelligence
This report analyzes the impact of environmental pressures on the Healthcare Sector. Who Should Buy Senior executives and ESG executives in Healthcare industry.
-
Product Insights
Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cough can occur with many signs and symptoms which include stuffy nose, hoarseness, wheezing and shortness of breath, and heartburn or a sour taste in the mouth. The treatment for cough entails antihistamines, decongestants, antibiotics, and cough suppressants. The Cough pipeline market research report provides an overview of the Cough pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration...
-
Product Insights
P2X Purinoceptor 3 (P2RX3) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
P2X purinoceptor 3 is a protein encoded by the P2RX3 gene. It belongs to the family of purinoceptors. This receptor functions as a ligand-gated ion channel and transduce ATP-evoked nociceptor activation. This receptor is important for peripheral pain responses, and also participates in pathways controlling urinary bladder volume reflexes. The P2X Purinoceptor 3 drugs in development market research report provides an in-depth analysis of P2X Purinoceptor 3 (P2RX3) targeted pipeline therapeutics. The report provides comprehensive information on the P2X Purinoceptor...
-
Product Insights
Sterilization Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Sterilization equipment is used to kill all the microbes (sterilization) from objects. On the basis of application, sterilization is of three types: physical, chemical and ultraviolet. GlobalData's Medical Devices sector report, “Sterilization Equipment (General Surgery) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Sterilization Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Sterilization Equipment report provides key information and...
-
Product Insights
Mumps – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Mumps - Global Clinical Trials Review, H2, 2021" provides an overview of Mumps Clinical trials scenario. This report provides top line data relating to the clinical trials on Mumps. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
-
Product Insights
Mumps Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Mumps Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Mumps Clinical trials scenario. This report provides top line data relating to the clinical trials on Mumps. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Rubella (German Measles) Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Rubella (German Measles) Global Clinical Trials Review, H1, 2020" provides an overview of Rubella (German Measles) Clinical trials scenario. This report provides top line data relating to the clinical trials on Rubella (German Measles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Alzheimer’s Disease Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Alzheimer's Disease Global Clinical Trials Review, H1, 2017" provides an overview of Alzheimer's Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Alzheimer's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Bordetella pertussis Infections Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Bordetella pertussis Infections Global Clinical Trials Review, H1, 2017" provides an overview of Bordetella pertussis Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Bordetella pertussis Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016" provides an overview of Bordetella pertussis Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Bordetella pertussis Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Diphtheria Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Diphtheria Global Clinical Trials Review, H2, 2016" provides an overview of Diphtheria clinical trials scenario. This report provides top line data relating to the clinical trials on Diphtheria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Tetanus Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Tetanus Global Clinical Trials Review, H2, 2016" provides an overview of Tetanus clinical trials scenario. This report provides top line data relating to the clinical trials on Tetanus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
OpportunityAnalyzer: Head and Neck Squamous Cell Carcinoma – Opportunity Analysis and Forecast to 2024
The head and neck cancer (HNC) market is one currently dominated by generic chemotherapies, with little competition from branded therapies. The market landscape is set to undergo substantial growth between 2014 and 2024. The main drivers of growth will be an increase in the diagnosed HNC population and the launch of multiple premium-priced metastatic therapies, led by the class of immuno-oncology products. Historically, cytotoxic chemotherapies have comprised the bulk of the HNC market. Little competition between targeted therapies currently exists...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.